Medipixel

Medipixel is a Korean MedTech startup founded in 2017, specializing in AI solutions for diagnostic and therapeutic procedures in coronary interventions. The company has garnered significant attention for its innovative approach to improving disease diagnosis and surgical robot control using AI. With a team of AI experts in computer vision, deep learning, and reinforcement learning, Medipixel collaborates with top healthcare professionals, including the esteemed Seoul Asan Medical Center, to develop groundbreaking solutions for cardiovascular disease diagnosis and coronary intervention robots.

In October 2023, Medipixel secured a notable KRW17.00B Series B investment from a consortium of prominent investors, including Company K Partners, Premier Partners, DAYLI Partners, IMM Investment, Industrial Bank of Korea, Quad Asset Management, and SBI Investment Korea.

Medipixel's current offerings include:

1. AI-Based Diagnosis Solution: Enabling doctors to identify lesions, perform vessel segmentation, and analyze lesion status during coronary angiography in just one second.

2. Guide & Planning Solution: Providing clear visualization of the coronary artery to facilitate confident guidewire manipulation, crucial for cases such as CTO, while eliminating the need for contrast to avoid potential patient reactions.

3. Automated Navigation Engine: Automating navigation through coronary arteries and controlling robotic units to deliver devices to the destination efficiently.

Medipixel's innovative solutions and successful funding underscore its potential in revolutionizing medical diagnostics and interventions and position the company as a compelling opportunity for investors and professionals passionate about leveraging deep learning in the healthcare industry.